Interroll Holding AG released its first-half 2026 financials on Friday, delivering results that were broadly in line with market expectations for orders, sales and operating profit, though net income fell short of consensus by roughly 7%.
On the orders side, the company recorded CHF295.2 million for the first six months, a 3.9% increase on a reported basis compared with the same period last year, and slightly above the consensus figure of CHF294.6 million. In local-currency terms, orders rose by 8.5%, a gain the company attributed to improving customer demand and higher project activity. The reported number was affected by the appreciation of the Swiss franc.
Sales expanded to CHF269.9 million, up 9% on a reported basis and 14.1% in local currency. That top-line result exceeded the consensus sales expectation of CHF258.5 million. Management highlighted momentum in the EMEA region and a broad-based recovery across Asia Pacific, and said the company is regaining market share in China.
EBIT for the first half was CHF27.0 million, marginally below the CHF27.6 million recorded in the same period of 2025 and narrowly below the consensus estimate of CHF27.1 million. The company attributed the decline in part to increased spending on research and development and innovation, targeted investments to strengthen regional and key account sales, and costs tied to recent acquisition activity, including amortization from purchase price allocation.
Net profit amounted to CHF19.8 million, down 7% from CHF21.2 million in the first half of 2025, and beneath the consensus estimate of CHF21.5 million. Operating cash flow reached CHF39.4 million, outperforming expectations by about 7%.
Free cash flow was negative CHF19.4 million in H1, a shortfall the company said was impacted by the acquisition of the Royal Apollo Group.
Interroll did not provide full-year guidance for 2026. Management said it expects commercial activity to pick up in the second half of the year. The firm cited a newly configured sales organization in the Americas as a driver of stronger commercial momentum in H2, and pointed to a dedicated research and development hub in China as a contributor to improved local results.
Context and implications
The first-half results show expansion in orders and revenue on both reported and local-currency bases, balanced against margin pressure from stepped-up investments and acquisition-related costs. The company is signalling that its actions in commercial organization and localized R&D are intended to support a stronger second half of 2026.